Vertex Pharmaceuticals Inc.
$VRTX
Public valuation for Vertex Pharmaceuticals Inc. (VRTX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$522.81
Fairly Valued
Fair Value Estimate
$488
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $571.39
9% higher than current
Key Metrics
Market Cap
$132.5B
Forward P/E
24.1x
Operating Margin
37.4%
Revenue Growth
10.0%
PEG Ratio
2.50
Get free watchlist alerts
Join the waitlist for valuation updates on $VRTX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.